An in vitro evaluation of antibacterial effect of silver nanoparticles on Staphylococcus aureus isolated from bovine subclinical mastitis

African Journal of Biotechnology

Volumn 10, Issue 52, 2011, Pages 10795-10797

  Dehkordi, Saied Habibian ^a   Hosseinpour, Fatemeh ^a   Kahrizangi, Azizollah Ebrahimi ^a  

^a SHAHREKORD UNIVERSITY   (Iran)

Author keywords

Bovine mastitis; Silver nanoparticles; Staphylococcus aureus

Indexed keywords

SILVER NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BOVINE MASTITIS; BROTH DILUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 80052829161     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/ajb11.1499     Document Type: Article

References (15)

1. Bradley AJ (2002). Bovine mastitis: An evolving disease. Vet. J. 164(2): 116-128.
2. Cho KH, Park JE, Osaka T, Park SG (2005). The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochim. Acta. 51(5): 956-960.
3. Dowling DP, Betts AJ, Pope C, McConnell ML, Eloy R, Arnaud MN (2003). Anti-bacterial silver coatings exhibiting enhanced activity through the addition of platinum. Surf. Coat. Technol. 163-164: 637-640.
4. Grier N (1983). Silver and its compounds. In: Disinfection, sterilization and preservation, Block S, (Eds.), Lea & Febiger, Philadelphia, USA. pp: 380-428.
5. Karimuribo ED, Kusiluka LJ, Mdegela RH, Kapaga AM, Sindato C, Kambarage DM (2005). Studies on mastitis, milk quality and health risks associated with consumption of milk from pastoral herds in dodoma and morogoro regions, tanzania. J. Vet. Sci. 6(3): 213-221.
6. Lee HJ, Yeo SY, Jeong SH (2003). Antibacterial effect of nanosized silver colloidal solution on textile fabrics. J. Mater. Sci. 38(10): 2199-2204.
7. McDonnell G, Russell A (1999). Antiseptics and disinfectants: Activity, action, and resistance. Clin. Microbiol. Rev. 12(1): 147-179.
8. Merisko-Liversidge E, Liversidge GG, Cooper ER (2003). Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 18(2): 113-120.
9. Mitchell JM, Griffiths MW, McEwen SA, McNab WB, Yee AJ (1998). Antimicrobial drug residues in milk and meat: Causes, concerns, prevalence, regulations, tests, and test performance. J. Food Prot. 61(6): 742-756.
10. Nunes SF, Bexiga R, Cavaco LM, Vilela CL (2007). Technical note: Antimicrobial susceptibility of portuguese isolates of staphylococcus aureus and staphylococcus epidermidis in subclinical bovine mastitis. J. Dairy Sci. 90(7): 3242-3246.
11. Pal S, Tak YK, Song JM (2007). Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 73(6): 1712-1720.
12. Quinn PJ, Carter ME, Markey BK, Carter GR (1994). Staphylococcus species. In: Clinical Veterinary Microbiology (Eds.). Mosby, London, UK. pp: 118-126.
13. Schneider M, Valle M, Woehrle F, Boisrame B (2004). Pharmacokinetics of marbofloxacin in lactating cows after repeated intramuscular administrations and pharmacodynamics against mastitis isolated strains. J. Dairy Sci. 87(1): 202-211.
14. Ugur A, Ceylan Ö (2003). Occurrence of resistance to antibiotics, metals, and plasmids in clinical strains of staphylococcus spp. Arch. Med. Res. 34(2): 130-136.
15. Yeo SY, Lee HJ, Jeong SH (2003). Preparation of nanocomposite fibers for permanent antibacterial effect. J. Mater. Sci. 38(10): 2143-2147.